Twitter

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / XGN - Exagen Inc. anticipates $65M revenue for 2025 amid ASP growth and new biomarker launches

XGN - Exagen Inc. anticipates $65M revenue for 2025 amid ASP growth and new biomarker launches

May, 05 2025 04:52 PM Exagen Inc.

2025-05-05 16:52:35 ET

More on Exagen

Exagen Inc. (XGN) Q1 2025 Earnings Call Transcript
Exagen: Buy An Undervalued Diagnostics Developer That Is On The Path To Profitability
Exagen Inc. (XGN) Q4 2024 Earnings Call Transcript
Exagen announces senior secured credit facility
Seeking Alpha’s Quant Rating on Exagen

For further details see:

Exagen Inc. anticipates $65M revenue for 2025 amid ASP growth and new biomarker launches

Stock Information

Company Name:	Exagen Inc.
Stock Symbol:	XGN
Market:	NASDAQ
Website:	exagen.com

XGN XGN Quote XGN Short XGN News XGN Articles XGN Message Board

Get XGN Alerts

News, Short Squeeze, Breakout and More Instantly...

Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.